Chargement en cours...
The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy
Deflazacort is the most commonly prescribed corticosteroid for the treatment of Duchenne muscular dystrophy in Canada. We review the long term experience with deflazacort treatment at two centers in Canada; Montreal and Toronto. Deflazacort has benefitted both cohorts by prolonged ambulation, preser...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pacini Editore SpA
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440807/ https://ncbi.nlm.nih.gov/pubmed/22655512 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|